ArticleCell death & disease2026
LMO7-mediated POLR2A degradation promotes cellular senescence through the MDM4/p53/p21 axis.
Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Silk Fibroin Peptides Promote Extracellular Matrix Homeostasis in Photoaging via Modulation of the ITGB1/FAK-TGF-β/Smad Signaling Axis.Molecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As the largest subunit of RNA polymerase II, POLR2A plays an irreplaceable role in gene expression, with the regulation of its own expression and physiological function having attracted widespread attention. Here we report POLR2A as a critical guardian against cellular senescence. A significant decline in POLR2A expression was observed in senescent cells and certain tissues of aging mice. Whereas its depletion dramatically induced cellular senescence, conversely, activating endogenous POLR2A expression in senescent cells using CRISPRa technology alleviated the senescent phenotype. We further demonstrated that POLR2A-induced senescence is p53-dependent, as evidenced by the activation of the p53/p21 pathway upon POLR2A knockdown and the rescue of the senescence phenotype following co-depletion of POLR2A and p53. Bioinformatic analysis on RNA-seq data from POLR2A depletion and replicative senescent cells led to the identification of MDM4 as the key mediator of p53 upregulation following POLR2A knockdown. Most intriguingly, immunoprecipitation assay further revealed that the E3 ligase LMO7 was recruited to POLR2A to promote the ubiquitination and proteasomal degradation of POLR2A under cellular senescence. Depletion of LMO7 abolished the ubiquitination and reduction of POLR2A in H₂O₂-induced senescent cells. Taken together, we concluded that the LMO7-induced POLR2A degradation drived cellular senescence through the MDM4/p53/p21 axis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.